Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  1996-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8641836
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.

  1996cited by this paper
• Hypoxic Induction of Endothelial Cell Growth Factors in Retinal Cells: Identification and Characterization of Vascular Endothelial Growth Factor (VEGF) as the Mitogen

  1995cited by this paper
• Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

  1995cited by this paper
• Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.

  1995cited by this paper
• Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia

  1995cited by this paper
• Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy.

  1994cited by this paper
• Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

  1994cited by this paper
• Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

  1994cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

  1993cited by this paper
• VEGF/VPF: the angiogenesis factor found?

  1993cited by this paper
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

  1992cited by this paper
• Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.

  1992cited by this paper
• Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-retinal barrier.

  1992cited by this paper
• Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.

  1992cited by this paper
• Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs.

  1990cited by this paper
• Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family.

  1989cited by this paper
• The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model.

  1980cited by this paper
• [Secotrial diabetic retinopathy in a case of partial atrophy of the optic nerve (author's transl)].

  1975cited by this paper
• The effect of hyperbaric oxygenation on retinal ischemia.

  1971cited by this paper
• RUBY LASER PHOTOCOAGULATION OF EARLY DIABETIC NEOVASCULAR RETINOPATHY

  1970cited by this paper
• Ruby laser photocoagulation of early diabetic neovascular retinopathy. Preliminary report of a long-term controlled study.

  1970cited by this paper
• Effect of Oxygen on Developing Retinal Vessels with Particular Reference to the Problem of Retrolental Fibroplasia

  1954cited by this paper

• Bispecific receptor decoy proteins inhibit ocular neovascularization via simultaneous blockade of vascular endothelial growth factor A and C.

  2025cites this paper
• Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product

  2024cites this paper
• Animal Models of Retinopathy of Prematurity: Advances and Metabolic Regulators

  2024cites this paper
• Phosphoinositide 3-kinase as a therapeutic target in angiogenic disease.

  2023cites this paper
• lncRNA DHFRL1-4 knockdown attenuates cerebral ischemia/reperfusion injury by upregulating the levels of angiogenesis-related genes

  2022cites this paper
• Animal Models of Retinopathy of Prematurity

  2021cites this paper
• The effect of treatment on retinal microvasculature in children with unilateral amblyopia.

  2021cites this paper
• Association Between Intravitreal Aflibercept and Serious Non-ocular Haemorrhage Compared with Intravitreal Ranibizumab: A Multicentre Observational Cohort Study

  2020cites this paper
• The developmental changes of retinal microvasculature in children: a quantitative analysis using OCT angiography.

  2020cites this paper
• Safety of anti-VEGF treatments in a diabetic rat model and retinal cell culture

  2019cites this paper
• A safety and immunogenicity study of immunization with hVEGF26-104/RFASE in cynomolgus monkeys.

  2018cites this paper
• Functional Characterization of Abicipar-Pegol, an Anti-VEGF DARPin Therapeutic That Potently Inhibits Angiogenesis and Vascular Permeability.

  2018cites this paper
• Reviews Animal Models of Retinal Vein Occlusion

  2017cites this paper
• Photocoagulation of the Retinal Nonperfusion Area Prevents the Expression of the Vascular Endothelial Growth Factor in an Animal Model.

  2017cites this paper
• Animal Models of Retinal Vein Occlusion.

  2017cites this paper
• Protective effects on the retina after ranibizumab treatment in an ischemia model

  2017cites this paper
• MicroRNA-9 Couples Brain Neurogenesis and Angiogenesis.

  2017cites this paper
• Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases

  2017cites this paper
• Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective.

  2017cites this paper
• Revisiting the mouse model of oxygen-induced retinopathy

  2016cites this paper
• History of the mouse model of OIR Initial clinical observations

  2016cites this paper
• VEGF: From Discovery to Therapy: The Champalimaud Award Lecture

  2016cites this paper
• VEGF expression is regulated by HIF‐1α and ARNT in 3D KYSE‐70, esophageal cancer cell spheroids

  2016cites this paper
• Ten years of anti-vascular endothelial growth factor therapy

  2016cites this paper
• Validation of Cross-Species Reactivity of the VEGF-A/PDGFRβ Bifunctional Antibody PF-06653157

  2016cites this paper
• Focusing on metabolomic dysregulation and modulation of retinal metabolism to develop novel therapeutic strategies for diabetic retinopathy

  2015cites this paper
• PEARLS AND PITFALLS IN DIAGNOSIS AND MANAGEMENT OF COATS DISEASE

  2015cites this paper
• Adrenomedullin Up-regulates the Expression of Vascular Endothelial Growth Factor in Epithelial Ovarian Carcinoma Cells via JNK/AP-1 Pathway

  2015cites this paper
• Quantifying Vascular Markers in Cancer Using Targeted Microbubbles

  2015cites this paper
• Iris rubeosis, severe respiratory failure and retinopathy of prematurity--case report.

  2014cites this paper
• The Harvard angiogenesis story.

  2014cites this paper
• Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model.

  2014cites this paper
• Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis.

  2014cites this paper
• Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.

  2014cites this paper
• Biological Therapies for Cancer

  2013cites this paper
• Vascular endothelial growth factor a in intraocular vascular disease.

  2013cites this paper
• Chapter 26 – Basic Mechanisms of Pathological Retinal and Choroidal Angiogenesis

  2013cites this paper
• In Silico Structural and Functional Characterization of the RSUME Splice Variants

  2013cites this paper
• Resistin Promotes the Expression of Vascular Endothelial Growth Factor in Ovary Carcinoma Cells

  2013cites this paper
• Pathophysiology of Retinal Vein Occlusions

  2012cites this paper
• The Related Transcriptional Enhancer Factor-1 Isoform, TEAD4216, Can Repress Vascular Endothelial Growth Factor Expression in Mammalian Cells

  2012cites this paper
• Examining The Role Of Angiogenic Factors And Early Developmental Defects In The Pathogenesis Of Pre-Eclampsia In A Mouse Model, Bph/5

  2011cites this paper
• Management of Neovascular AMD

  2011cites this paper
• Adenoviral Delivery of VEGF121 Early in Pregnancy Prevents Spontaneous Development of Preeclampsia in BPH/5 Mice

  2011cites this paper
• COMPARISON OF TWO DOSES OF INTRAVITREAL BEVACIZUMAB AS PRIMARY TREATMENT FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION: Results of the Pan American Collaborative Retina Study Group at 24 Months

  2010cites this paper
• Aqueous Humor Endothelin-1 (Et-1), Vascular Endothelial Growth Factor (VEGF) and Cyclooxygenase-2 (COX-2) levels in Mexican Glaucomatous Patients

  2010cites this paper
• Intra-ocular expression of vascular endothelial growth factor (VEGF) and pigment epithelial-derived factor (PEDF) in a case of Eales’ disease by immunohistochemical analysis: a case report

  2010cites this paper
• EUROPEAN SCHOOL OF MOLECULAR MEDICINE

  2010cites this paper
• Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion.

  2010cites this paper
• Experimentelle Untersuchungen zur Bedeutung von Wachstums- und Gerinnungsfaktoren bei der Entstehung maligner Ergüsse

  2010cites this paper
• Spectral imaging based in vivo model system for characterization of tumor microvessel response to vascular targeting agents

  2010cites this paper
• Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration

  2009cites this paper
• BEVACIZUMAB COMPARED WITH MACULAR LASER GRID PHOTOCOAGULATION FOR CYSTOID MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION

  2009cites this paper
• Vascular Endothelial Growth Factors In Eye Diseases Pathophysiology and New Therapeutic Strategies for Retinal and Choroideal Angiogenesis

  2009cites this paper
• Regulation of gene expression for therapy of age related macular degeneration

  2009cites this paper
• Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy

  2009cites this paper
• The Effect of Intravitreal Ranibizumab on the Fellow Untreated Eye with Subfoveal Scarring due to Exudative Age-Related Macular Degeneration

  2009cites this paper
• Induction of Neuronal Vascular Endothelial Growth Factor Expression by cAMP in the Dentate Gyrus of the Hippocampus Is Required for Antidepressant-Like Behaviors

  2009cites this paper
• Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration

  2009cites this paper
• A reproducible and quantifiable model of choroidal neovascularization induced by VEGF A165 after subretinal adenoviral gene transfer in the rabbit

  2008cites this paper
• Pharmacokinetics and safety of bevacizumab administered in combination with cisplatin and paclitaxel in cynomolgus monkeys

  2008cites this paper
• Regulation of retinal blood flow in health and disease.

  2008cites this paper
• Molecular and histological changes following central retinal artery occlusion in a mouse model.

  2008cites this paper
• Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: is 6 months still appropriate?

  2008cites this paper
• Therapeutic anti-VEGF antibodies.

  2008cites this paper
• Food and Drug Administration approval process for ophthalmic drugs in the US

  2008cites this paper
• Retinal and Choroidal Circulations

  2008cites this paper
• Hypoxia Inducible Factor-1 and VEGF Induction

  2008cites this paper
• Occlusion veineuse expérimentale : modifications de l'oxygénation de la rétine hypoxique par l'hyperoxie, le carbogène et des inhibiteurs de l'anhydrase carbonique

  2008cites this paper
• Long-term genetic modification of the ocular outflow tract and the retinal pigment epithelium with feline immunodeficiency viral vectors

  2008cites this paper
• Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes.

  2007cites this paper
• INTRAVITREAL BEVACIZUMAB INJECTIONS FOR TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION: Six-Month Results of a Prospective Trial

  2007cites this paper
• INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR CENTRAL AND HEMICENTRAL RETINAL VEIN OCCLUSIONS: IBeVO Study

  2007cites this paper
• Gene Therapy for Neovascular Retinopathies

  2006cites this paper
• endothelial growth factor in eye disease Role of vascular permeability factor/vascular

  2006cites this paper
• Comparative effects of early postnatal ibuprofen and indomethacin on VEGF, IGF-I, and GH during rat ocular development.

  2006cites this paper
• Role of vascular endothelial growth factor in ocular angiogenesis.

  2006cites this paper
• Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.

  2006cites this paper
• VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells

  2006cites this paper
• Vascular endothelial growth factor biology: clinical implications for ocular treatments

  2006cites this paper
• Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration.

  2005cites this paper
• Avastin contains bevacizumab, a recombinant humanised monoclonal antibody produced by DNA technology. The applicant sought a marketing authorisation for Avastin in combination with 5- fluorouracil/folinic acid containing regimens for the first-line treatment of patients with metastatic carcinoma

  2005cites this paper
• Pegaptanib sodium for the treatment of neovascular age-related macular degeneration

  2005cites this paper
• How do endothelial cells orientate?

  2005cites this paper
• Concomitant Administration of Bevacizumab, Irinotecan, 5-Fluorouracil, and Leucovorin: Nonclinical Safety and Pharmacokinetics

  2005influential citation
• Mechanisms of Angiogenesis

  2005cites this paper
• ANGIOGENESIS, CHOROIDAL NEOVASCULARIZATION, AND THE COAGULATION SYSTEM

  2005cites this paper
• Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.

  2005cites this paper
• Adeno-Associated Virus-Mediated Expression of Vascular Endothelial Growth Factor Peptides Inhibits Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy

  2005cites this paper
• Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

  2004cites this paper
• Angiogenesis and ophthalmic disease

  2004cites this paper
• Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.

  2004cites this paper
• Ectodomain shedding of VEGF183, a novel isoform of vascular endothelial growth factor, promotes its mitogenic activity in vitro

  2004cites this paper
• Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: Involvement of cytosolic phospholipase A2 activity.

  2004influential citation
• Aptamers, Intramers, and Vascular Endothelial Growth Factor

  2004cites this paper
• Development and pathology of the hyaloid, choroidal and retinal vasculature.

  2004cites this paper
• Retinopathy of Prematurity

  2003cites this paper
• Protein kinases and the hypoxia-inducible factor-1, two switches in angiogenesis.

  2003cites this paper
• VEGF expression by ganglion cells in central retina before formation of the foveal depression in monkey retina: Evidence of developmental hypoxia

  2003cites this paper
• Regulation of angiogenesis by MAP kinase pathways during cardiac ischaemia and reperfusion

  2003cites this paper